Ipamorelin and CJC 1295

December 22, 2021 |

What’s Human Growth Hormone?

Human growth hormone (HGH) is produced by the pituitary gland and is responsible for growth in children and adolescents. HGH peaks when we are about 20 years old, then declines. 

On average, adults lose up to 14% of the human growth hormone per decade after 30, which contributes to many of the signs we attribute to aging. This includes low energy, slower recovery from wounds or workouts, slow metabolism, and more.

What is Ipamorelin?

Ipamorelin peptides mimic ghrelin and bind to the ghrelin receptor in the brain, which stimulates the release of growth hormone from the pituitary gland. 

Peptide therapy uses the sequences of amino acid chains already present in the body to regulate and rejuvenate functions. They tell other cells what to do, replacing or mimicking the functions of naturally occurring peptides

What is CJC 1295?

CJC 1295 is a peptide that increases the body’s production of a hormone that induces the pituitary to release growth hormone. 

Benefits of Combining CJC 1295 and Ipamorelin

When combined, these two peptides work on two different pathways to increase growth hormone. Generally, when combined, we see a 3-5 fold increase in growth hormone release over ipamorelin alone. This will increase the benefits of your peptide therapy over using a single peptide alone.